BEIJING AIRDOC TECHNOLOGY CO., LTD. Financials Beijing Airdoc Technology Co., Ltd.
Equities
2251
CNE100004QQ9
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.98 HKD | +0.94% |
|
-0.13% | +23.80% |
| Apr. 17 | Beijing Airdoc Arm Setting Up 500 Million Yuan Fund | MT |
| Mar. 27 | Beijing Airdoc Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 3,241 | 1,295 | 1,139 | 1,412 | - | - |
| Enterprise Value (EV) 1 | 1,445 | 34.97 | 219.4 | 462.6 | 462.6 | 424.6 |
| P/E ratio | -17.8 x | -7.15 x | -8.59 x | -51 x | 55.1 x | 27.5 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 28.1 x | 11.4 x | 5.58 x | 4.16 x | 2.61 x | 2.01 x |
| EV / Revenue | 12.5 x | 0.31 x | 1.08 x | 1.36 x | 0.86 x | 0.6 x |
| EV / EBITDA | -11.4 x | -0.22 x | -1.94 x | -19.3 x | 10.2 x | 5 x |
| EV / FCF | -10.3 x | -0.09 x | 27.3 x | -5.2 x | -463 x | 10.9 x |
| FCF Yield | -9.7% | -1,115% | 3.66% | -19.2% | -0.22% | 9.18% |
| Price to Book | 1.39 x | 0.77 x | 0.74 x | 0.95 x | 0.93 x | 0.91 x |
| Nbr of stocks (in thousands) | 103,568 | 103,568 | 103,568 | 102,548 | - | - |
| Reference price 2 | 31.29 | 12.51 | 11.00 | 13.77 | 13.77 | 13.77 |
| Announcement Date | 3/17/22 | 3/23/23 | 3/27/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 47.67 | 115.2 | 113.7 | 204 | 339.5 | 541 | 704 |
| EBITDA 1 | - | -126.7 | -159.6 | -113.4 | -24 | 45.5 | 85 |
| EBIT 1 | - | -142.2 | -182.3 | -145.3 | -40 | 25.5 | 60 |
| Operating Margin | - | -123.48% | -160.4% | -71.24% | -11.78% | 4.71% | 8.52% |
| Earnings before Tax (EBT) 1 | - | -142.5 | -182.7 | -145.9 | -34 | 31 | 71 |
| Net income 1 | - | -142.6 | -180 | -132.5 | -30.5 | 25.5 | 55 |
| Net margin | - | -123.83% | -158.37% | -64.98% | -8.98% | 4.71% | 7.81% |
| EPS 2 | -1.360 | -1.760 | -1.750 | -1.280 | -0.2700 | 0.2500 | 0.5000 |
| Free Cash Flow 1 | - | -140.1 | -389.7 | 8.023 | -89 | -1 | 39 |
| FCF margin | - | -121.64% | -342.91% | 3.93% | -26.22% | -0.18% | 5.54% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | 45.88% |
| FCF Conversion (Net income) | - | - | - | - | - | - | 70.91% |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 10/25/21 | 3/17/22 | 3/23/23 | 3/27/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 1,796 | 1,260 | 920 | 949 | 949 | 987 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -140 | -390 | 8.02 | -89 | -1 | 39 |
| ROE (net income / shareholders' equity) | - | -12.8% | -10.3% | -8.27% | -2% | 1.7% | 3.6% |
| ROA (Net income/ Total Assets) | - | -12.2% | -9.91% | -7.74% | -2.4% | 1.3% | 2.7% |
| Assets 1 | - | 1,165 | 1,817 | 1,712 | 1,271 | 1,962 | 2,037 |
| Book Value Per Share 2 | - | 22.50 | 16.20 | 14.90 | 14.60 | 14.80 | 15.10 |
| Cash Flow per Share 2 | - | -1.390 | -3.690 | 0.2300 | -0.3200 | 0.2300 | 0.7000 |
| Capex 1 | - | 28 | 9.3 | 15.3 | 18.5 | 40 | 35 |
| Capex / Sales | - | 24.31% | 8.18% | 7.52% | 5.45% | 7.39% | 4.97% |
| Announcement Date | 10/25/21 | 3/17/22 | 3/23/23 | 3/27/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
13.77
CNY
Average target price
18.69
CNY
Spread / Average Target
+35.79%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +23.80% | 195M | |
| -3.90% | 29.91B | |
| +31.35% | 8.52B | |
| +33.81% | 4.21B | |
| -29.31% | 2.68B | |
| -9.44% | 1.6B | |
| -20.44% | 1.37B | |
| -34.19% | 1.14B | |
| +4.92% | 938M | |
| -43.66% | 787M |
- Stock Market
- Equities
- 2251 Stock
- Financials Beijing Airdoc Technology Co., Ltd.
